Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aragonès, J. M.
Right arrow Articles by Illa, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aragonès, J. M.
Right arrow Articles by Illa, I.
Related Collections
Right arrow All Neuromuscular Disease
Right arrow Myasthenia
Right arrow All epidemiology
Right arrow Incidence studies

Neurology 2003;60:1024-1026
© 2003 American Academy of Neurology
Brief Communications

Myasthenia gravis

A higher than expected incidence in the elderly

J. M. Aragonès, MD, I. Bolíbar, MD, X. Bonfill, MD PhD, E. Bufill, MD, A. Mummany, MD, F. Alonso, MD and I. Illa, MD PhD

From the Unit of Neurology (Drs. Aragonès, Bufill, and Alonso), Hospital General de Vic; Departments of Clinical Epidemiology and Public Health (Dr. Bolíbar and Bonfill) and Neurology (Dr. Illa), Hospital de la Santa Creu i Sant Pau; and Unit of Neurology (Dr. Mummany), Clínica de Vic, Barcelona, Spain.

Address correspondence and reprint requests to Dr. J.M. Aragonès, Francesc Plà "el vigatà," 1, 08500 Vic, Barcelona, Spain; e-mail: jmaragones{at}hgv.es

This 10-year (1991 to 2000) prospective study of MG in the county of Osona (Barcelona, Spain) reveals an annual incidence rate of 21.27 cases per million inhabitants (95% CI 13.89 to 31.16). Incidence increased from 5.03 x 106 in the age group of 0 to 14 years to 14.68 x 106 in the age group of 15 to 64 years and to 63.38 x 106 in the older population. These results, the highest reported to date, may be explained by the population aging.




This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
N Matsui, S Nakane, Y Nakagawa, K Kondo, T Mitsui, T Matsumoto, K Arisawa, and R Kaji
Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan
J. Neurol. Neurosurg. Psychiatry, October 1, 2009; 80(10): 1168 - 1171.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
J F Owe, A K Daltveit, and N E Gilhus
Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001
J. Neurol. Neurosurg. Psychiatry, February 1, 2006; 77(2): 203 - 207.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
F. E. Somnier
Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis
Neurology, September 27, 2005; 65(6): 928 - 930.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.